Literature DB >> 11502659

Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism.

C E Sandrock1, S Murin.   

Abstract

STUDY
OBJECTIVES: To our knowledge, the predictors of respiratory failure (RF) and long-term mechanical ventilation have not previously been examined in patients with wound botulism associated with black tar heroin use.
DESIGN: Retrospective case series.
SETTING: A large university hospital. PATIENTS: Twenty consecutive patients from 1991 to 1998 with a diagnosis of wound botulism associated with drug use as identified through chart records from a single institution.
RESULTS: The predominant mode of drug use was subcutaneous (75%). Fifteen of 20 patients (75%) developed RF. The clinical presentation was similar in groups with RF and without RF. Of those patients who received antitoxin within 12 h of presentation, 57% required mechanical ventilation compared to 85% of patients receiving the antitoxin after 12 h. The median durations of mechanical ventilation were 11 days for those who received antitoxin within 12 h, and 54 days for those who did not receive antitoxin within 12 h. The duration of mechanical ventilation for patients receiving antibiotics within 12 h was 35 days vs 54 days for patients receiving antibiotics after 12 h. Early tracheostomy (< 10 days after initial intubation) was associated with a shorter duration of mechanical ventilation (median, 45 days vs 60 days, respectively).
CONCLUSION: Early antitoxin administration may decrease the need for and duration of mechanical ventilation among patients with wound botulism. Early tracheostomy may be beneficial for patients with RF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502659     DOI: 10.1378/chest.120.2.562

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Botulism as a cause of respiratory failure in injecting drug users.

Authors:  S FitzGerald; R Lyons; J Ryan; W Hall; C Gallagher
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

2.  Wound botulism from heroin skin popping.

Authors:  Larry E Davis; Molly K King
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

3.  Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.

Authors:  Thomas J Stopka; Alexandra Lutnick; Lynn D Wenger; Kathryn Deriemer; Estella M Geraghty; Alex H Kral
Journal:  Am J Epidemiol       Date:  2012-05-04       Impact factor: 4.897

4.  Incubation period as a clinical predictor of botulism: analysis of previous izushi-borne outbreaks in Hokkaido, Japan, from 1951 to 1965.

Authors:  H Nishiura
Journal:  Epidemiol Infect       Date:  2006-05-10       Impact factor: 2.451

5.  Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.

Authors:  Agam K Rao; Jeremy Sobel; Kevin Chatham-Stephens; Carolina Luquez
Journal:  MMWR Recomm Rep       Date:  2021-05-07

6.  First case of type E wound botulism diagnosed using real-time PCR.

Authors:  Ingrid Artin; Per Björkman; Jonas Cronqvist; Peter Rådström; Elisabet Holst
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

7.  Ophthalmoplegia and slurred speech in an intravenous drug user.

Authors:  Jaime Vera; Anke Hensiek; Charles Woodrow; Francesca Crawley; Sanjeev Krishna
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

8.  Wound botulism in injection drug users.

Authors:  Wiltrud Maria Kalka-Moll; Ute Aurbach; Reiner Schaumann; Rosemarie Schwarz; Harald Seifert
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

9.  Wound botulism in injection drug users: time to antitoxin correlates with intensive care unit length of stay.

Authors:  Steven R Offerman; Melissa Schaefer; Joseph G Thundiyil; Matthew D Cook; James F Holmes
Journal:  West J Emerg Med       Date:  2009-11

10.  Wound botulism presenting as dysphagia to an ENT ward.

Authors:  Lucy Qian Li; Andrew Cadamy; Andrew Seaton
Journal:  BMJ Case Rep       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.